Viyash Scientific Ltd

Mon 31/08/2026,15:59:42 | NSE : VIYASH

₹263.60-3.80 (-1.42%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 268.00

Previous Close

₹ 267.40

Volume

3318934

Mkt Cap ( ₹ Cr)

₹ 11595.96

High

₹ 268.50

Low

₹ 262.70

52 Week High

₹ 298.00

52 Week Low

₹ 168.55

Book Value Per Share

₹ 67.99

Dividend Yield

0.00

Face Value

₹ 2.00

What's Your Call?

Collective community sentiment on Viyash Scientific Ltd

Your Vote -

Buy

87.65%

Hold

6.23%

Sell

6.12%

87.65%

12763 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

263.60

105

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

105

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Viyash Scientific Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Viyash Scientific Q1 net profit zooms 520.77% at Rs 20.92 cr

    26 Aug 2026, 12:20PM The company reported standalone net profit of Rs 20.92 crore for the quarter ended June 30, 2026 as compared to Rs 3.37 crore in the same period last

  • Viyash Scientific - Analysts/Institutional Investor Meet/Con. Call Updates

    16 Aug 2026, 11:16AM Viyash Scientific Limited has informed the Exchange about Transcript

  • Viyash Scientific - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    16 Aug 2026, 11:25AM Earning call Transcript Q1 FY 2026-27

  • Viyash Scientific - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    12 Aug 2026, 7:49PM Audio Recording of Earnings call pertaining to the unaudited Financial Results (Consolidated and Standalone) for the quarter ended June 30, 2026

  • Viyash Scientific - Analysts/Institutional Investor Meet/Con. Call Updates

    12 Aug 2026, 7:42PM Viyash Scientific Limited has informed the Exchange about Link of Earning call Recording

  • Viyash Scientific - Copy of Newspaper Publication

    12 Aug 2026, 12:58PM Viyash Scientific Limited has informed the Exchange about Copy of Newspaper Publication for Q1 FY 27 Financial Results.

  • Viyash Scientific - Investor Presentation

    12 Aug 2026, 9:56AM Viyash Scientific Limited has informed the Exchange about Investor Presentation

  • Viyash Scientific - Announcement under Regulation 30 (LODR)-Investor Presentation

    12 Aug 2026, 10:02AM Investor Presentation Q1 FY 2026-2027

  • Viyash Scientific - Shareholders meeting

    11 Aug 2026, 8:32PM Viyash Scientific Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 11, 2026. Further, the compan

  • Viyash Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    11 Aug 2026, 8:32PM Voting results and scrutinizer Report

  • Viyash Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    11 Aug 2026, 8:31PM Voting results and scrutinizer Report

  • Viyash Scientific - Shareholders meeting

    11 Aug 2026, 6:26PM Viyash Scientific Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 11, 2026

  • Viyash Scientific - Shareholder Meeting / Postal Ballot-Outcome of AGM

    11 Aug 2026, 6:19PM Outcome of the 41st AGM held on August 11, 2026

  • Viyash Scientific - Press Release

    11 Aug 2026, 3:38PM Viyash Scientific Limited has informed the Exchange regarding a press release dated August 11, 2026, titled ""Press Release for Q1 FY 2026-27"".

  • Viyash Scientific - General Updates

    11 Aug 2026, 1:27PM Viyash Scientific Limited has informed the Exchange about General Updates Allotment of ESOP under Viyash Scientific Limited -Employee Stock Option Sch

  • Viyash Scientific - Outcome of Board Meeting

    11 Aug 2026, 1:05PM Viyash Scientific Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

  • Viyash Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    11 Aug 2026, 8:32PM Voting results and scrutinizer Report

  • Viyash Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    11 Aug 2026, 8:31PM Voting results and scrutinizer Report

  • Viyash Scientific - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    11 Aug 2026, 3:43PM Press Release for Q1 FY 2026-27

  • Viyash Scientific - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    11 Aug 2026, 1:20PM Allotment of ESOP under Viyash Scientific Limited -Employee Stock Option Scheme 2026

  • Viyash Scientific - Board Meeting Outcome for Outcome Of Board Meeting

    11 Aug 2026, 1:14PM Outcome of Board Meeting

  • Viyash Scientific - Unaudited Financial Results For Q1 FY 2026-2027

    11 Aug 2026, 1:11PM Unaudited Financial Results for Q1 FY 2026-2027

  • Viyash Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    11 Aug 2026, 8:32PM Voting results and scrutinizer Report

  • Viyash Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    11 Aug 2026, 8:31PM Voting results and scrutinizer Report

  • Viyash Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    11 Aug 2026, 8:32PM Voting results and scrutinizer Report

  • Viyash Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    11 Aug 2026, 8:31PM Voting results and scrutinizer Report

  • Viyash Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    11 Aug 2026, 8:32PM Voting results and scrutinizer Report

  • Viyash Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    11 Aug 2026, 8:31PM Voting results and scrutinizer Report

  • Viyash Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    11 Aug 2026, 8:32PM Voting results and scrutinizer Report

  • Viyash Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    11 Aug 2026, 8:31PM Voting results and scrutinizer Report

  • Viyash Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    11 Aug 2026, 8:32PM Voting results and scrutinizer Report

  • Viyash Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    11 Aug 2026, 8:31PM Voting results and scrutinizer Report

  • Viyash Scientific - Analysts/Institutional Investor Meet/Con. Call Updates

    3 Aug 2026, 6:59PM Viyash Scientific Limited has informed the Exchange about Schedule of meet

  • Viyash Scientific - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    3 Aug 2026, 6:49PM Intimation of Q1 FY27 Earnings Conference Call / Discussion on Financial Results for Quarter Ended June 30, 2026

  • Viyash Scientific - Board Meeting Intimation for Quarterly Results For Q1 FY 2026-27

    3 Aug 2026, 6:45PM Viyash Scientific Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider an

  • Viyash Scientific - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    1 Aug 2026, 6:24PM ESOP Allotment

  • Viyash Scientific - General Updates

    1 Aug 2026, 6:21PM Viyash Scientific Limited has informed the Exchange about ESOP Allotment

  • Viyash Scientific - General Updates

    21 Jul 2026, 5:45PM Viyash Scientific Limited has informed the Exchange about General Updates - Intimation under Regulation 30 of SEBILODR

  • Viyash Scientific - Intimation Under Regulation 30 Of SEBI LODR

    21 Jul 2026, 5:34PM Intimation under Regulation 30 of SEBI LODR

  • Viyash Scientific has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    20 Jul 2026, 7:40PM As of June 2026, 61.31% is owned by Foreign Promoters, 38.60% by Public and 0.09% by Non Promoters-Non Public. <p align=justify> Top two Promoters hol

  • Viyash Scientific - Copy of Newspaper Publication

    18 Jul 2026, 4:28PM Viyash Scientific Limited has informed the Exchange about Copy of Newspaper Publication- 41st AGM

  • Viyash Scientific - Letter To The Shareholders Annual Report FY 2025-26

    17 Jul 2026, 7:00PM Letter to the shareholders Annual Report FY 2025-26

  • Viyash Scientific - General Updates

    17 Jul 2026, 6:56PM Viyash Scientific Limited has informed the Exchange about letter to the shareholder

  • Viyash Scientific - Updates

    17 Jul 2026, 5:03PM Viyash Scientific Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for the Financial Year 2025-26'.

  • Viyash Scientific - Shareholders meeting

    17 Jul 2026, 4:58PM Viyash Scientific Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 11, 2026

  • Viyash Scientific - Business Responsibility and Sustainability Reporting (BRSR)

    17 Jul 2026, 4:35PM Business Responsibility and Sustainability Reporting(BRSR)

  • Viyash Scientific - Notice Of 41St Annual General Meeting

    17 Jul 2026, 4:26PM Notice of 41st Annual General Meeting

  • Viyash Scientific - Reg. 34 (1) Annual Report.

    17 Jul 2026, 4:21PM Annual Report for FY 2025-26

  • Viyash Scientific - Copy of Newspaper Publication

    14 Jul 2026, 3:58PM Viyash Scientific Limited has informed the Exchange about Copy of Newspaper Publication -AGM Notice

  • Viyash Scientific - General Updates

    7 Jul 2026, 9:59PM Viyash Scientific Limited has informed the Exchange about Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obliga

  • Viyash Scientific - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Dis

    7 Jul 2026, 9:53PM Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure) Requirements, 2015.

  • Viyash Scientific - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    6 Jul 2026, 3:39PM Viyash Scientific Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Viyash Scientific - Disclosure under SEBI Takeover Regulations

    6 Jul 2026, 12:16PM CA Harbor Investments and CA Hull Investments has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange

  • Viyash Scientific - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    6 Jul 2026, 3:26PM Certificate under Regulation 74(5) of SEBI(DP)Regulations, 2018

  • Viyash Scientific - Shareholders meeting

    29 Jun 2026, 3:47PM Viyash Scientific Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regar

  • Viyash Scientific - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    29 Jun 2026, 3:41PM Postal Ballot Result and Scrutinizer's Report

  • Viyash Scientific - Trading Window

    26 Jun 2026, 5:52PM Viyash Scientific Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations

  • Viyash Scientific - Analysts/Institutional Investor Meet/Con. Call Updates

    25 Jun 2026, 12:56PM Viyash Scientific Limited has informed the Exchange about Presentation

  • Viyash Scientific - Announcement under Regulation 30 (LODR)-Investor Presentation

    25 Jun 2026, 12:59PM Investor Presentation : Viyash Investor Day -2026

  • Viyash Scientific - Analysts/Institutional Investor Meet/Con. Call Updates

    17 Jun 2026, 4:29PM Viyash Scientific Limited has informed the Exchange about Schedule of meet

  • Viyash Scientific - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    17 Jun 2026, 4:20PM Investor meeting -Viyash Investor Day - 2026

  • Viyash Scientific - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    11 Jun 2026, 12:04PM Earning call Audio Recording

  • Viyash Scientific - Press Release

    8 Jun 2026, 1:07PM Viyash Scientific Limited has informed the Exchange regarding a press release dated Jun 08, 2026.

  • Viyash Scientific - General Updates

    8 Jun 2026, 1:03PM Viyash Scientific Limited has informed the Exchange about General Updates-Acquisition

  • Viyash Scientific to acquire Italy&rsquo;s BioForLife for Rs 188 cr

    8 Jun 2026, 12:56PM Viyash Scientific Limited, through its wholly owned subsidiary Alivira Animal Health Limited, has signed a binding agreement to acquire a 100% stake i

  • Viyash Scientific - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    8 Jun 2026, 12:44PM Press Release

  • Viyash Scientific - Announcement under Regulation 30 (LODR)-Acquisition

    8 Jun 2026, 12:41PM We hereby inform you that AAHL Ireland, Stepdown wholly owned subsidiary of the Company has entered into a Binding agreement today i.e. June 08, 2026

  • Sequent Scientific

    9 Mar 2023 , 10:17AM The transaction contemplated under the agreement to acquire 100% stake in Tineta Pharma has not been materialised, and the acquisition will not happen. Positive read through.

  • Sequent Scientific

    17 Jan 2022 , 10:45AM The board of directors have appointed Mr Rajaram Narayanan as the MD and CEO of the company effective 11 April 2022. Mr. Narayanan, who has served in senior leadership roles across the pharmaceutical, consumer goods and services industries and has a strong track record of leading revenue and profitability growth across multiple industries including pharmaceuticals. This bodes well for Sequent Scientific from a growth perspective, Positive.

  • Sequent Scientific signs agreement to buy Brazilian animal healthcare co

    16 Dec 2021 , 12:25PM Sequent Scientific signs definitive agreement to acquire stake in Nourrie Saude e Nutricao Animal Ltda

  • SeQuent Scientific

    15 Jul 2021 , 9:39AM Announced the EUGMP approval of its tablets dosage manufacturing line in Turkey. The approval was further complimented by the successful renewal of EUGMP license for 8 other manufacturing lines for various dosage forms in Turkey. In addition to the EUGMP, the manufacturing lines in Turkey also hold GMP certificates from Turkish, Saudi, Ethiopian and Sudanese authorities. Overall the company has 120 products registered and is the third largest player in Turkey ruminant market with a consolidated market share of 10%. The EUGMP approval is positive as it would enable the company to cater to regulated market of Europe.

  • SeQuent announces launch of Citramox LA in EU

    10 Dec 2020 , 3:09PM SeQuent Scientific launches Citramox LA 150 mg/ml Suspension Injection for Cattle and Pigs in 10 European countries

  • SeQuent announces launch of inhouse developed Halofusol in EU

    1 Dec 2020 , 12:26PM SeQuent Scientific launches Halofusol oral solution for calves in 19 European countries

  • Sequent Scientific signs agreement for acquisition of 40% stake in Provet

    23 Sep 2020 , 11:22AM Sequent Scientific enters into definitive agreement with Dr. Huseyin Aydin for the acquisition of 40% stake in Provet Veteriner Urunleri San. Ve Tic. A

  • Sequent Scientific Ltd

    11 May 2020 , 12:47PM Enters into Binding Agreements to Acquire a Majority Stake in SeQuent Scientific Ltd; Mandatory open offer to trigger at Rs 86 per share, a premium of ~7% over 8th May 2020 closing price

  • SeQuent Scientific receives EIR from USFDA

    20 Aug 2019 , 2:19PM SeQuent Scientific receives EIR from USFDA for its Analytical Laboratory at Bengaluru
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Viyash Scientific Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 3221.188 1187.034 1133.683 1077.461 1056.588
Liabilities 3221.188 1187.034 1133.683 1077.461 1056.588
Equity 87.37 50.06 49.886 49.887 49.674
Gross Profit 234.531 -11.383 -26.664 -26.36 -0.75
Net Profit 75.867 15.794 0.622 -6.08 14.799
Cash From Operating Activities 119.12 -1.125 -26.944 37.746 9.364
NPM(%) 5.48 8.86 0.36 -2.73 6.73
Revenue 1382.058 178.257 168.518 222.685 219.626
Expenses 1147.527 189.64 195.182 249.045 220.376
ROE(%) 2.53 0.52 0.02 -0.2 0.49

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
08 Sep 2021 0.5 25 0 283.05
21 Aug 2019 0.2 10 0 68.05
20 Nov 2017 0.2 10 0 100.1

Peers

Other companies within the same industry or sector that are comparable to Viyash Scientific Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 897.90 -0.08 22.71 150.53 -26.19 0.56
Lotus Eye Hospital and Institute Ltd 109.08 -1.30 1558.29 548.50 0.39 0.00
Vaishali Pharma Ltd 8.06 -3.01 25.19 3440.94 15.42 0.00
Astec Lifesciences Ltd 560.70 -3.57 0.00 587.69 -363.14 0.00

Company Info

2003 - Hon'ble High Court of Bombay approved the Scheme of Amalgamation of company with P I Drugs & Pharmaceuticals Ltd. 2007 -PI Drugs & Pharmaceuticals Ltd has informed that Dr. Gopakumar G Nair has joined the Board as Independent Director effective June 20, 2007. 2008 - PI Drugs Board recommends dividend @ 10% 2009 - PI Drugs & Pharmaceuticals Ltd equity shareholders approve Scheme of Amalgamation - PI Drugs & Pharmaceuticals Ltd Board recommends Dividend@ 10% - PI Drugs & Pharmaceuticals Ltd - Change of name of the Company from PI Drugs & Pharmaceuticals Ltd to Sequent Scientific Ltd. 2010 - SeQuent Scientific to invest Rs. 150 crore in three new therapeutic segments - Signs an MoU with Karnataka Government. 2011 - PI Drugs & Pharmaceuticals Ltd Appoined Mr. Vinayak Hegde as Company Secretary . 2012 - PI Drugs - Issue of Warrants on Preferential basis - PI Drugs - Alloted 10,00,000 fully paid equity shares of Rs. 10/- each --Registered Office of the Company has been shifted from No. 116, Vardhaman Industrial Complex, Lal Bahaddur Shastri Marg, Thane west - 400 601 to 301, 'Dosti Pinnacle', 3rd Floor, Plot No. E7, Road No. 22, Wagle Indl. Estate, Thane (W) - 400 604. 2013 -Sequent receives US FDA Approval for ITS API Drug Manufacturing Facility at Mangalore. -Sequent Scientific Ltd & Shasun Pharmaceuticals Ltd announce Joint Venture to Create Leading Animal Health Company. 2014 -SeQuent Scientific Limited announces completion of Sale of Specialty Chemicals division to Songwon Industrial Group. -Sequent Scientific to acquire the business of Arvee Synthesis Acquisition to provide impetus to Human API business. -Sequent Scientific - Updates - Alivira completes acquisition of majority stake in Provet Veterinary Products AS, Turkey. 2015 -SeQuent Scientific to acquire Animal Health business of Lyka Exports -SeQuent Scientific inaugurates new Analytical Services Centre at Bengaluru 2016 - SeQuent Scientific to acquire controlling stake in Indo Phyto Chemicals Forays into steroids and hormone -Sequent Scientific commences production in Vizag facility 2017 -SeQuent Scientific said that , its arm Alivira has received approval from the US health regulator for its animal health API facility in Visakhapatnam in Andhra Pradesh. 2018 -SeQuent Scientific Limited (SeQuent), has said that its wholly owned subsidiary Alivira Animal Health Limited ("Alivira") through Alivira Ireland, has signed an agreement with simultaneous closing to acquire 100 per cent of Bremer Pharma, Zydus Cadila's Animal Health Business in Germany . 2020 -Sequent Scientific announces addition of new state-of-art Animal Health R&D Centre at Mumbai -SeQuent Scientific receives EIR from US FDA for its Analytical Laboratory at Bengaluru 2021 -Sequent Scientific forays into pet segment in Brazil -The company has said that Evance Saude Animal Health Ltda ('Evance'), Brazil, a subsidiary of the Company has entered into a definitive agreement for acquisition of 100% stake in Nourrie Sa£de e Nutri‡ao Animal Ltda ('Nourrie').\r\n\r\nIn this regard, -SeQuent Scientific Limited (SeQuent) has said that European Union Good Manufacturing Practices (EUGMP) approval of its tablets dosage manufacturing line in Turkey. -SeQuent received CEP approval for Diclazuril API2022-The Company BOD approved Acquisition of entire 100% stake in Tineta Pharma Private Limited.2024-The company Receives Prequalification Approval from World Health Organization for Albendazole API.2025-SeQuent Scientific and Viyash Lifesciences Receive NCLT Approval for TransformationalMerger. 

2003 - Hon'ble High Court of Bombay approved the Scheme of Amalgamation of company with P I Drugs & Pharmaceuticals Ltd. 2007 -PI Drugs & Pharmaceuticals Ltd has informed that Dr. Gopakumar G Nair has joined the Board as Independent Director effective June 20, 2007. 2008 - PI Drugs Board recommends dividend @ 10% 2009 - PI Drugs & Pharmaceuticals Ltd equity shareholders approve Scheme of Amalgamation - PI Drugs & Pharmaceuticals Ltd Board recommends Dividend@ 10% - PI Drugs & Pharmaceuticals Ltd - Change of name of the Company from PI Drugs & Pharmaceuticals Ltd to Sequent Scientific Ltd. 2010 - SeQuent Scientific to invest Rs. 150 crore in three new therapeutic segments - Signs an MoU with Karnataka Government. 2011 - PI Drugs & Pharmaceuticals Ltd Appoined Mr. Vinayak Hegde as Company Secretary . 2012 - PI Drugs - Issue of Warrants on Preferential basis - PI Drugs - Alloted 10,00,000 fully paid equity shares of Rs. 10/- each --Registered Office of the Company has been shifted from No. 116, Vardhaman Industrial Complex, Lal Bahaddur Shastri Marg, Thane west - 400 601 to 301, 'Dosti Pinnacle', 3rd Floor, Plot No. E7, Road No. 22, Wagle Indl. Estate, Thane (W) - 400 604. 2013 -Sequent receives US FDA Approval for ITS API Drug Manufacturing Facility at Mangalore. -Sequent Scientific Ltd & Shasun Pharmaceuticals Ltd announce Joint Venture to Create Leading Animal Health Company. 2014 -SeQuent Scientific Limited announces completion of Sale of Specialty Chemicals division to Songwon Industrial Group. -Sequent Scientific to acquire the business of Arvee Synthesis Acquisition to provide impetus to Human API business. -Sequent Scientific - Updates - Alivira completes acquisition of majority stake in Provet Veterinary Products AS, Turkey. 2015 -SeQuent Scientific to acquire Animal Health business of Lyka Exports -SeQuent Scientific inaugurates new Analytical Services Centre at Bengaluru 2016 - SeQuent Scientific to acquire controlling stake in Indo Phyto Chemicals Forays into steroids and hormone -Sequent Scientific commences production in Vizag facility 2017 -SeQuent Scientific said that , its arm Alivira has received approval from the US health regulator for its animal health API facility in Visakhapatnam in Andhra Pradesh. 2018 -SeQuent Scientific Limited (SeQuent), has said that its wholly owned subsidiary Alivira Animal Health Limited ("Alivira") through Alivira Ireland, has signed an agreement with simultaneous closing to acquire 100 per cent of Bremer Pharma, Zydus Cadila's Animal Health Business in Germany . 2020 -Sequent Scientific announces addition of new state-of-art Animal Health R&D Centre at Mumbai -SeQuent Scientific receives EIR from US FDA for its Analytical Laboratory at Bengaluru 2021 -Sequent Scientific forays into pet segment in Brazil -The company has said that Evance Saude Animal Health Ltda ('Evance'), Brazil, a subsidiary of the Company has entered into a definitive agreement for acquisition of 100% stake in Nourrie Sa£de e Nutri‡ao Animal Ltda ('Nourrie').\r\n\r\nIn this regard, -SeQuent Scientific Limited (SeQuent) has said that European Union Good Manufacturing Practices (EUGMP) approval of its tablets dosage manufacturing line in Turkey. -SeQuent received CEP approval for Diclazuril API2022-The Company BOD approved Acquisition of entire 100% stake in Tineta Pharma Private Limited.2024-The company Receives Prequalification Approval from World Health Organization for Albendazole API.2025-SeQuent Scientific and Viyash Lifesciences Receive NCLT Approval for TransformationalMerger. 

Parent Organisation

Viyash Scientific Ltd.

Founded

28/06/1985

Managing Director

Mr.Rajaram Narayanan

NSE Symbol

VIYASHEQ

FAQ